Alpine Immune Sciences, Inc. announced that Andrew Sandler, MD was appointed as Chief Medical Officer of the company effective August 17, 2022. Dr. Sandler brings over 25 years of industry experience and clinical development expertise and leadership to the Alpine team. Dr. Sandler joins Alpine from Kiadis Pharma, where he was Chief Medical Officer.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
64.97 USD | +0.02% | 0.00% | +240.87% |
1st Jan change | Capi. | |
---|---|---|
+240.87% | 4.46B | |
+11.02% | 115B | |
+12.46% | 106B | |
-4.16% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.31% | 17.56B | |
-40.50% | 17.32B | |
+6.29% | 14.03B | |
+31.61% | 12.13B |
- Stock Market
- Equities
- ALPN Stock
- News Alpine Immune Sciences, Inc.
- Alpine Immune Sciences, Inc. Appoints Andrew Sandler, MD as Chief Medical Officer of the Company, Effective August 17, 2022